♥

Syngene International Limited

ISIN : INE398R01022
NSE : SYNGENE
BSE : 539268
Face Value : 10
Industry : Miscellaneous

EPS : 12.69
EPS (TTM) : 11.98
Price to Earning (P/E) : 57.23
Book Value : 104.19
Price to Bookvalue (P/B) : 6.97
Dividend Yield : 0 %
Return on Equity (ROE) : 13.18 %
Return on Capital Employed (ROCE) : 15.55 %

Syngene International share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	395.65 - 390.95 -1.2 %
Low / High	380.35 - 395.65 4 %
Trade Volume	46,438
52 Week Low / High	380.35 - 728.4 91.5 %

YOU MAY ALSO LIKE

High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Share Market basics for beginners
Share Market jargons in simple terms
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
Stock market course tutorial
Stock Market Investment Course explained in simple words.

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR SYNGENE INTERNATIONAL LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	6445	7681	7859	9944	8081	9101	8535	9169	7897	8910
Total Income	6600	7835	8031	10172	8317	9317	8828	9330	8078	9118
Total Expenditure	4717	5516	5549	6803	5962	6560	6220	6000	6199	6505
Other Income	155	154	172	228	236	216	293	161	181	208
Operating Profit	1883	2319	2482	3369	2355	2757	2608	3330	1879	2613
Interest	94	117	137	104	105	130	108	129	117	131
Exceptional Items						-74	-37		320
PBDT	1789	2202	2345	3265	2250	2553	2463	3201	2082	2482
Depreciation	861	902	946	956	1021	1046	1081	1111	1069	1109
Profit Before Tax	928	1300	1399	2309	1229	1507	1382	2090	1013	1373
Tax	189	280	302	522	295	342	267	204	256	312
Profit After Tax	739	1020	1097	1787	934	1165	1115	1886	757	1061
Net Profit	739	1020	1097	1787	934	1165	1115	1886	757	1061
Equity Capital	4014	4014	4014	4014	4020	4020	4020	4020	4025	4025
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	1.84	2.54	2.73	4.45	2.32	2.9	2.77	4.69	1.88	2.64
Diluted Eps After Extraordinary Items	1.83	2.53	2.71	4.43	2.32	2.9	2.77	4.69	1.88	2.64
Diluted Eps Before Extraordinary Items	1.83	2.53	2.71	4.43	2.32	2.9	2.77	4.69	1.88	2.64

STANDALONE QUARTERLY RESULT FOR SYNGENE INTERNATIONAL LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	6445	7681	7866	9944	7158	8307	7919	8647	7265	8213
Total Income	6600	7835	8038	10172	7387	8517	8207	8800	7442	8417
Total Expenditure	4726	5524	5562	6780	5524	6141	5924	5654	5783	6167
Other Income	155	154	172	228	229	210	288	153	177	204
Operating Profit	1874	2311	2476	3392	1863	2376	2283	3146	1659	2250
Interest	94	117	137	104	61	86	63	85	74	70
Exceptional Items						-74	-37		320
PBDT	1780	2194	2339	3288	1802	2216	2183	3061	1905	2180
Depreciation	861	902	946	881	887	909	936	957	917	937
Profit Before Tax	919	1292	1393	2407	915	1307	1247	2104	988	1243
Tax	187	277	298	517	162	291	249	206	249	277
Profit After Tax	732	1015	1095	1890	753	1016	998	1898	739	966
Net Profit	732	1015	1095	1890	753	1016	998	1898	739	966
Equity Capital	4014	4014	4014	4014	4020	4020	4020	4020	4025	4025
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	1.82	2.53	2.73	4.71	1.87	2.53	2.48	4.72	1.84	2.4
Diluted Eps After Extraordinary Items	1.82	2.51	2.71	4.68	1.87	2.53	2.48	4.72	1.84	2.41
Diluted Eps Before Extraordinary Items	1.82	2.51	2.71	4.68	1.87	2.53	2.48	4.72	1.84	2.41

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR SYNGENE INTERNATIONAL LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	26042	31929	34886
Total Income	27118	32638	35792
Total Expenditure	18629	22585	24742
Other Income	1076	709	906
Operating Profit	8489	10053	11050
Interest	241	452	472
Exceptional Items	-307		-111
PBDT	7941	9601	10467
Depreciation	3097	3665	4259
Profit Before Tax	4844	5936	6208
Tax	886	1292	1108
Profit After Tax	3958	4644	5100
Net Profit	3958	4644	5100
Equity Capital	4008	4014	4020
Face Value (IN RS)	10	10	10
Reserves	28968	32166	38557
Calculated EPS	9.88	11.57	12.69
Diluted Eps After Extraordinary Items	9.82	11.51	12.69
Diluted Eps Before Extraordinary Items	9.82	11.51	12.69

STANDALONE ANNUAL RESULT FOR SYNGENE INTERNATIONAL LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	26014	31935	32031
Total Income	27090	32644	32911
Total Expenditure	18628	22592	23243
Other Income	1076	709	880
Operating Profit	8462	10052	9668
Interest	241	452	295
Exceptional Items	-307		-111
PBDT	7914	9600	9262
Depreciation	3097	3591	3689
Profit Before Tax	4817	6009	5573
Tax	879	1279	908
Profit After Tax	3938	4730	4665
Net Profit	3938	4730	4665
Equity Capital	4008	4014	4020
Face Value (IN RS)	10	10	10
Reserves	28912	32175	37895
Calculated EPS	9.83	11.78	11.6
Diluted Eps After Extraordinary Items	9.77	11.72	11.61
Diluted Eps Before Extraordinary Items	9.77	11.72	11.61

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	2184.3 Cr	2604.2 Cr	3192.9 Cr	3492.4 Cr
Job Work/ Contract Receipts	0	0	3080.2 Cr	3373.3 Cr
Processing Charges / Service Income	2089.1 Cr	2506.7 Cr	0	0
Net Sales	2184.3 Cr	2604.2 Cr	3192.9 Cr	3488.6 Cr
Increase/Decrease in Stock	-25.2 Cr	-21.6 Cr	-42 Cr	56.7 Cr
Raw Material Consumed	551.7 Cr	770.6 Cr	0	0
Opening Raw Materials	20.2 Cr	29.4 Cr	0	0
Purchases Raw Materials	560.9 Cr	868.8 Cr	0	0
Closing Raw Materials	29.4 Cr	127.6 Cr	0	0
Power & Fuel Cost	57.4 Cr	64.8 Cr	69.2 Cr	69.7 Cr
Electricity & Power	57.4 Cr	64.8 Cr	69.2 Cr	69.7 Cr
Employee Cost	660.2 Cr	718.1 Cr	841.7 Cr	888.7 Cr
Salaries, Wages & Bonus	550 Cr	605.2 Cr	731.6 Cr	796 Cr
Contributions to EPF & Pension Funds	24.1 Cr	27.5 Cr	31.8 Cr	35.1 Cr
Workmen and Staff Welfare Expenses	25.6 Cr	35.8 Cr	43.9 Cr	45.3 Cr
Other Manufacturing Expenses	130.1 Cr	143.1 Cr	1078.8 Cr	1082 Cr
Repairs and Maintenance	130.1 Cr	143.1 Cr	176.6 Cr	208.4 Cr
General and Administration Expenses	120.5 Cr	148.5 Cr	219.9 Cr	264.1 Cr
Rent , Rates & Taxes	9.6 Cr	10.1 Cr	17.5 Cr	14.1 Cr
Insurance	16.2 Cr	17.8 Cr	25.4 Cr	26.1 Cr
Printing and stationery	2.4 Cr	3.2 Cr	3.9 Cr	3.9 Cr
Professional and legal fees	40.1 Cr	57.1 Cr	71.1 Cr	117.9 Cr
Traveling and conveyance	27.4 Cr	28.3 Cr	46.1 Cr	54.6 Cr
Selling and Distribution Expenses	6.4 Cr	11.7 Cr	18.5 Cr	20.3 Cr
Advertisement & Sales Promotion	3 Cr	9 Cr	15.1 Cr	17.3 Cr
Freight and Forwarding	3.4 Cr	2.7 Cr	3.4 Cr	3 Cr
Miscellaneous Expenses	30.1 Cr	28.5 Cr	74.1 Cr	92.7 Cr
Bad debts /advances written off	1.6 Cr	80 Lk	1 Cr	60 Lk
Provision for doubtful debts	1.6 Cr	4.6 Cr	0	4.9 Cr
Loss on disposal of fixed assets(net)	5.9 Cr	2 Cr	7.5 Cr	2.5 Cr
Loss on foreign exchange fluctuations	0	0	41.8 Cr	55.8 Cr
Total Expenditure	1531.2 Cr	1863.7 Cr	2260.2 Cr	2474.2 Cr
Other Income	83.3 Cr	108.4 Cr	72.6 Cr	90.6 Cr
Interest Received	62.3 Cr	46.5 Cr	60.3 Cr	76.1 Cr
Profits on sale of Investments	2.1 Cr	6.3 Cr	10.6 Cr	14.4 Cr
Foreign Exchange Gains	17.1 Cr	54.8 Cr	0	0
Operating Profit	736.4 Cr	848.9 Cr	1005.3 Cr	1105 Cr
Interest	27.7 Cr	24.1 Cr	45.2 Cr	47.2 Cr
Interest on Term Loan	17.4 Cr	7.2 Cr	18.2 Cr	18.2 Cr
PBDT	708.7 Cr	824.8 Cr	960.1 Cr	1057.8 Cr
Depreciation	274.5 Cr	309.7 Cr	366.5 Cr	425.9 Cr
Profit Before Taxation & Exceptional Items	434.2 Cr	515.1 Cr	593.6 Cr	631.9 Cr
Exceptional Income / Expenses	35 Cr	-30.7 Cr	0	-11.1 Cr
Profit Before Tax	469.2 Cr	484.4 Cr	593.6 Cr	620.8 Cr
Provision for Tax	64.3 Cr	88.6 Cr	129.2 Cr	110.8 Cr
Current Income Tax	74.6 Cr	83.7 Cr	106.1 Cr	123 Cr
Deferred Tax	16.5 Cr	20 Lk	12.2 Cr	-16.8 Cr
Profit After Tax	404.9 Cr	395.8 Cr	464.4 Cr	510 Cr
Consolidated Net Profit	404.9 Cr	395.8 Cr	464.4 Cr	510 Cr
Profit Balance B/F	1777.7 Cr	2182.5 Cr	2578.3 Cr	2972.5 Cr
Appropriations	2182.6 Cr	2578.3 Cr	3042.7 Cr	3482.5 Cr
Other Appropriation	10 Lk	0	70.2 Cr	46.5 Cr
Equity Dividend %	0	10	12.5	12.5
Earnings Per Share	10.12	9.88	11.57	12.69
Adjusted EPS	10.12	9.88	11.57	12.69

STANDALONE PROFIT / LOSS FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	2179.4 Cr	2601.4 Cr	3193.5 Cr	3206.9 Cr
Job Work/ Contract Receipts	0	0	3080.4 Cr	3067.3 Cr
Processing Charges / Service Income	2084.2 Cr	2503.9 Cr	0	0
Net Sales	2179.4 Cr	2601.4 Cr	3193.5 Cr	3203.1 Cr
Increase/Decrease in Stock	-25.2 Cr	-21.6 Cr	-42 Cr	56.6 Cr
Raw Material Consumed	551.7 Cr	770.6 Cr	0	0
Opening Raw Materials	20.2 Cr	29.4 Cr	0	0
Purchases Raw Materials	560.9 Cr	868.8 Cr	0	0
Closing Raw Materials	29.4 Cr	127.6 Cr	0	0
Power & Fuel Cost	57.4 Cr	64.4 Cr	69.2 Cr	54.2 Cr
Electricity & Power	57.4 Cr	64.4 Cr	69.2 Cr	54.2 Cr
Employee Cost	641.5 Cr	697.8 Cr	812.2 Cr	761.2 Cr
Salaries, Wages & Bonus	532.7 Cr	585.4 Cr	703.3 Cr	677.4 Cr
Contributions to EPF & Pension Funds	24.1 Cr	27.5 Cr	31.9 Cr	31.5 Cr
Workmen and Staff Welfare Expenses	25.2 Cr	35.7 Cr	44.8 Cr	41.9 Cr
Other Manufacturing Expenses	130 Cr	143.1 Cr	1078.8 Cr	1031.1 Cr
Repairs and Maintenance	130 Cr	143.1 Cr	176.6 Cr	192 Cr
General and Administration Expenses	136.1 Cr	168.7 Cr	250.4 Cr	314.8 Cr
Rent , Rates & Taxes	9.5 Cr	10.1 Cr	14.6 Cr	13.1 Cr
Insurance	16.2 Cr	17.6 Cr	23.4 Cr	23.2 Cr
Printing and stationery	2.4 Cr	3.2 Cr	3.9 Cr	3.5 Cr
Professional and legal fees	56.5 Cr	78.2 Cr	109.3 Cr	185 Cr
Traveling and conveyance	26.8 Cr	27.5 Cr	43.4 Cr	43.2 Cr
Selling and Distribution Expenses	6.1 Cr	11.8 Cr	18 Cr	16.2 Cr
Advertisement & Sales Promotion	2.7 Cr	9 Cr	14.6 Cr	14.7 Cr
Freight and Forwarding	3.4 Cr	2.8 Cr	3.4 Cr	1.5 Cr
Miscellaneous Expenses	30.5 Cr	28.8 Cr	74.3 Cr	90.3 Cr
Bad debts /advances written off	1.6 Cr	80 Lk	1 Cr	60 Lk
Provision for doubtful debts	1.6 Cr	4.6 Cr	0	1.9 Cr
Loss on disposal of fixed assets(net)	5.9 Cr	2 Cr	7.5 Cr	2.5 Cr
Loss on foreign exchange fluctuations	0	0	41.8 Cr	56.2 Cr
Total Expenditure	1528.1 Cr	1863.6 Cr	2260.9 Cr	2324.4 Cr
Other Income	83.3 Cr	108.4 Cr	72.6 Cr	88 Cr
Interest Received	62.3 Cr	46.5 Cr	60.3 Cr	74.9 Cr
Profits on sale of Investments	2.1 Cr	6.3 Cr	10.6 Cr	13 Cr
Foreign Exchange Gains	17.1 Cr	54.8 Cr	0	0
Operating Profit	734.6 Cr	846.2 Cr	1005.2 Cr	966.7 Cr
Interest	27.7 Cr	24.1 Cr	45.2 Cr	29.5 Cr
Interest on Term Loan	17.4 Cr	7.2 Cr	18.2 Cr	18.2 Cr
PBDT	706.9 Cr	822.1 Cr	960 Cr	937.2 Cr
Depreciation	274.5 Cr	309.7 Cr	359.1 Cr	368.8 Cr
Profit Before Taxation & Exceptional Items	432.4 Cr	512.4 Cr	600.9 Cr	568.4 Cr
Exceptional Income / Expenses	35 Cr	-30.7 Cr	0	-11.1 Cr
Profit Before Tax	467.4 Cr	481.7 Cr	600.9 Cr	557.3 Cr
Provision for Tax	63.7 Cr	87.9 Cr	127.9 Cr	90.8 Cr
Current Income Tax	73.6 Cr	82.9 Cr	104.7 Cr	99.8 Cr
Deferred Tax	16.9 Cr	30 Lk	12.3 Cr	-13.6 Cr
Profit After Tax	403.7 Cr	393.8 Cr	473 Cr	466.5 Cr
Consolidated Net Profit	403.7 Cr	393.8 Cr	473 Cr	466.5 Cr
Profit Balance B/F	1775.9 Cr	2179.5 Cr	2573.3 Cr	2976.1 Cr
Appropriations	2179.6 Cr	2573.3 Cr	3046.3 Cr	3442.6 Cr
Other Appropriation	10 Lk	0	70.2 Cr	46.5 Cr
Equity Dividend %	0	10	12.5	12.5
Earnings Per Share	10.09	9.83	11.78	11.6
Adjusted EPS	10.09	9.83	11.78	11.6

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR SYNGENE INTERNATIONAL LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	469.3 Cr	484.4 Cr	593.6 Cr	620.8 Cr
Adjustment	278.8 Cr	381.7 Cr	384.9 Cr	365.1 Cr
Changes In working Capital	36.7 Cr	-179.7 Cr	-18.2 Cr	181.3 Cr
Cash Flow after changes in Working Capital	784.8 Cr	686.4 Cr	960.3 Cr	1167.2 Cr
Cash Flow from Operating Activities	701.2 Cr	580.6 Cr	823.5 Cr	1042.1 Cr
Cash Flow from Investing Activities	-628.1 Cr	-611.5 Cr	-656.4 Cr	-495.6 Cr
Cash Flow from Financing Activitie	58 Cr	-31.3 Cr	-342.5 Cr	-551.4 Cr
Net Cash Inflow / Outflow	131.1 Cr	-62.2 Cr	-175.4 Cr	-4.9 Cr
Opening Cash & Cash Equivalents	193 Cr	323.3 Cr	261.8 Cr	89.5 Cr
Effect of Foreign Exchange Fluctuations	-80 Lk	70 Lk	3.1 Cr	1.1 Cr
Closing Cash & Cash Equivalent	323.3 Cr	261.8 Cr	89.5 Cr	85.7 Cr

STANDALONE CASH FLOW FOR SYNGENE INTERNATIONAL LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	467.4 Cr	481.7 Cr	600.9 Cr	557.3 Cr
Adjustment	278.6 Cr	381.3 Cr	375.3 Cr	289.2 Cr
Changes In working Capital	34.8 Cr	-176.6 Cr	-4.1 Cr	165.3 Cr
Cash Flow after changes in Working Capital	780.8 Cr	686.4 Cr	972.1 Cr	1011.8 Cr
Cash Flow from Operating Activities	698 Cr	582.2 Cr	838.4 Cr	913.4 Cr
Cash Flow from Investing Activities	-628.1 Cr	-611.5 Cr	-688.2 Cr	-383.5 Cr
Cash Flow from Financing Activitie	58 Cr	-31.3 Cr	-340.2 Cr	-536.3 Cr
Net Cash Inflow / Outflow	127.9 Cr	-60.6 Cr	-190 Cr	-6.4 Cr
Opening Cash & Cash Equivalents	191.8 Cr	318.9 Cr	259 Cr	72.1 Cr
Effect of Foreign Exchange Fluctuations	-80 Lk	70 Lk	3.1 Cr	90 Lk
Closing Cash & Cash Equivalent	318.9 Cr	259 Cr	72.1 Cr	66.6 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Equity - Authorised	500 Cr	500 Cr	500 Cr	500 Cr
Equity - Issued	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Equity Paid Up	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Face Value	10	10	10	10
Total Reserves	2344.4 Cr	2809.3 Cr	3151.2 Cr	3786.6 Cr
Securities Premium	144.5 Cr	171.1 Cr	216.7 Cr	216.7 Cr
Capital Reserves	0	0	0	3.9 Cr
Profit & Loss Account Balance	2182.5 Cr	2578.3 Cr	2972.5 Cr	3436 Cr
General Reserves	0	0	0	26.1 Cr
Reserve excluding Revaluation Reserve	2344.4 Cr	2809.3 Cr	3151.2 Cr	3786.6 Cr
Shareholder's Funds	2821.4 Cr	3297.6 Cr	3618 Cr	4257.6 Cr
Secured Loans	512.4 Cr	531.5 Cr	489 Cr	100 Cr
Term Loans - Banks	146.4 Cr	151.9 Cr	139.7 Cr	100 Cr
Deferred Tax Assets / Liabilities	-89.1 Cr	-65.6 Cr	-69.6 Cr	-40.7 Cr
Deferred Tax Assets	188.9 Cr	190.7 Cr	194.2 Cr	182.6 Cr
Deferred Tax Liability	99.8 Cr	125.1 Cr	124.6 Cr	141.9 Cr
Other Long Term Liabilities	364.4 Cr	471.4 Cr	492.1 Cr	608.9 Cr
Long Term Provisions	52 Cr	34.4 Cr	43.7 Cr	40.7 Cr
Total Non-Current Liabilities	839.7 Cr	971.7 Cr	955.2 Cr	708.9 Cr
Trade Payables	241.6 Cr	232.8 Cr	258 Cr	255.5 Cr
Sundry Creditors	241.6 Cr	232.8 Cr	258 Cr	255.5 Cr
Other Current Liabilities	571.6 Cr	655.8 Cr	778.2 Cr	726.8 Cr
Bank Overdraft / Short term credit	4.5 Cr	20 Lk	0	10 Cr
Advances received from customers	381 Cr	435.3 Cr	531.4 Cr	502.7 Cr
Short Term Borrowings	259.9 Cr	258.1 Cr	86.3 Cr	41.7 Cr
Secured ST Loans repayable on Demands	0	258.1 Cr	86.3 Cr	41.7 Cr
Working Capital Loans- Sec	0	258.1 Cr	0	0
Short Term Provisions	59.9 Cr	82.2 Cr	65.7 Cr	120.3 Cr
Provision for Tax	13.4 Cr	24 Cr	14.7 Cr	47.6 Cr
Total Current Liabilities	1133 Cr	1228.9 Cr	1188.2 Cr	1144.3 Cr
Total Liabilities	4794.1 Cr	5498.2 Cr	5761.4 Cr	6110.8 Cr
Gross Block	3404.4 Cr	3882.5 Cr	4481.4 Cr	4945.8 Cr
Less: Accumulated Depreciation	1241 Cr	1528.2 Cr	1862.6 Cr	2136.9 Cr
Net Block	2163.4 Cr	2354.3 Cr	2618.8 Cr	2808.9 Cr
Capital Work in Progress	237.2 Cr	346.4 Cr	176.9 Cr	836.8 Cr
Non Current Investments	316.3 Cr	308.8 Cr	94.1 Cr	34.7 Cr
Long Term Investment	316.3 Cr	308.8 Cr	94.1 Cr	34.7 Cr
Unquoted	316.3 Cr	308.8 Cr	94.1 Cr	38.7 Cr
Long Term Loans & Advances	115 Cr	151.2 Cr	181.1 Cr	239.6 Cr
Other Non Current Assets	155.5 Cr	131.6 Cr	217.1 Cr	189.5 Cr
Total Non-Current Assets	2987.4 Cr	3292.3 Cr	3336.1 Cr	4151.9 Cr
Currents Investments	423.3 Cr	763.8 Cr	824.4 Cr	513.2 Cr
Quoted	148.4 Cr	223.2 Cr	147.6 Cr	230.8 Cr
Unquoted	316.3 Cr	308.8 Cr	94.1 Cr	38.7 Cr
Inventories	59.6 Cr	179.4 Cr	332.8 Cr	238.5 Cr
Raw Materials	29.4 Cr	127.6 Cr	0	0
Work-in Progress	21.2 Cr	39.7 Cr	73.3 Cr	23.9 Cr
Finished Goods	9 Cr	12.1 Cr	20.5 Cr	13.2 Cr
Stores and Spare	0	0	239 Cr	201.4 Cr
Sundry Debtors	339.2 Cr	507.7 Cr	529.3 Cr	441.5 Cr
Debtors more than Six months	6.2 Cr	44.4 Cr	17.5 Cr	29.2 Cr
Debtors Others	339.2 Cr	473.3 Cr	520.1 Cr	425.5 Cr
Cash and Bank	642.6 Cr	517.9 Cr	531.7 Cr	563.5 Cr
Balances at Bank	642.6 Cr	517.9 Cr	531.7 Cr	563.5 Cr
Other Current Assets	173.9 Cr	157 Cr	132.4 Cr	106.4 Cr
Interest accrued and or due on loans	12.7 Cr	32.9 Cr	39.2 Cr	16.6 Cr
Prepaid Expenses	24.2 Cr	28.2 Cr	31.2 Cr	16.4 Cr
Short Term Loans and Advances	168.1 Cr	80.1 Cr	74.7 Cr	95.8 Cr
Advances recoverable in cash or in kind	142.2 Cr	32.4 Cr	29.6 Cr	39.8 Cr
Total Current Assets	1806.7 Cr	2205.9 Cr	2425.3 Cr	1958.9 Cr
Net Current Assets (Including Current Investments)	673.7 Cr	977 Cr	1237.1 Cr	814.6 Cr
Total Assets	4794.1 Cr	5498.2 Cr	5761.4 Cr	6110.8 Cr
Contingent Liabilities	429.9 Cr	547.8 Cr	621.9 Cr	637.1 Cr
Total Debt	772.3 Cr	789.6 Cr	575.3 Cr	141.7 Cr
Book Value	68.61	0	0	0
Adjusted Book Value	68.61	80.09	88.51	104.19

STANDALONE BALANCE SHEET FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Equity - Authorised	500 Cr	500 Cr	500 Cr	500 Cr
Equity - Issued	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Equity Paid Up	400 Cr	400.8 Cr	401.4 Cr	402 Cr
Face Value	10	10	10	10
Total Reserves	2341.4 Cr	2804.2 Cr	3154.7 Cr	3772.1 Cr
Securities Premium	144.5 Cr	171.1 Cr	216.7 Cr	267.7 Cr
Capital Reserves	0	0	0	3.9 Cr
Profit & Loss Account Balance	2179.5 Cr	2573.3 Cr	2976.1 Cr	3396.1 Cr
Reserve excluding Revaluation Reserve	2341.4 Cr	2804.2 Cr	3154.7 Cr	3772.1 Cr
Shareholder's Funds	2818.3 Cr	3292 Cr	3618.9 Cr	4191.5 Cr
Secured Loans	512.4 Cr	531.5 Cr	489 Cr	100 Cr
Term Loans - Banks	146.4 Cr	151.9 Cr	139.7 Cr	100 Cr
Deferred Tax Assets / Liabilities	-88.7 Cr	-65.1 Cr	-79.5 Cr	-49.8 Cr
Deferred Tax Assets	188.5 Cr	190.3 Cr	201.6 Cr	178.3 Cr
Deferred Tax Liability	99.8 Cr	125.2 Cr	122.1 Cr	128.5 Cr
Other Long Term Liabilities	364.4 Cr	471.4 Cr	329.2 Cr	405.7 Cr
Long Term Provisions	52 Cr	34.4 Cr	41.7 Cr	38.1 Cr
Total Non-Current Liabilities	840.1 Cr	972.2 Cr	780.4 Cr	494 Cr
Trade Payables	239.1 Cr	235.3 Cr	260.4 Cr	254 Cr
Sundry Creditors	239.1 Cr	235.3 Cr	260.4 Cr	254 Cr
Other Current Liabilities	571.6 Cr	655.9 Cr	749.8 Cr	689 Cr
Bank Overdraft / Short term credit	4.5 Cr	20 Lk	0	10 Cr
Advances received from customers	381 Cr	435.3 Cr	531 Cr	498.6 Cr
Short Term Borrowings	259.9 Cr	258.1 Cr	86.3 Cr	41.7 Cr
Secured ST Loans repayable on Demands	0	258.1 Cr	86.3 Cr	41.7 Cr
Working Capital Loans- Sec	0	258.1 Cr	0	0
Short Term Provisions	59.8 Cr	82.2 Cr	60.8 Cr	113.9 Cr
Provision for Tax	13.3 Cr	24 Cr	12.7 Cr	46.2 Cr
Total Current Liabilities	1130.4 Cr	1231.5 Cr	1157.3 Cr	1098.6 Cr
Total Liabilities	4788.8 Cr	5495.7 Cr	5768.5 Cr	5784.1 Cr
Gross Block	3404.4 Cr	3882.5 Cr	3993.7 Cr	4293.7 Cr
Less: Accumulated Depreciation	1241 Cr	1528.2 Cr	1781.8 Cr	2016.9 Cr
Net Block	2163.4 Cr	2354.3 Cr	2211.9 Cr	2276.8 Cr
Capital Work in Progress	237.2 Cr	346.4 Cr	126.2 Cr	758.3 Cr
Non Current Investments	316.6 Cr	309.1 Cr	116.4 Cr	435 Cr
Long Term Investment	316.6 Cr	309.1 Cr	116.4 Cr	435 Cr
Unquoted	316.6 Cr	309.1 Cr	116.4 Cr	439 Cr
Long Term Loans & Advances	115.1 Cr	150.7 Cr	164.5 Cr	230.3 Cr
Other Non Current Assets	155.5 Cr	131.6 Cr	217.1 Cr	189.5 Cr
Total Non-Current Assets	2987.8 Cr	3292.1 Cr	2884.2 Cr	3932.3 Cr
Currents Investments	423.3 Cr	763.8 Cr	824.4 Cr	492.6 Cr
Quoted	148.4 Cr	223.2 Cr	147.6 Cr	210.2 Cr
Unquoted	316.6 Cr	309.1 Cr	116.4 Cr	439 Cr
Inventories	59.6 Cr	179.4 Cr	332.8 Cr	234 Cr
Raw Materials	29.4 Cr	127.6 Cr	0	0
Work-in Progress	21.2 Cr	39.7 Cr	73.3 Cr	23.9 Cr
Finished Goods	9 Cr	12.1 Cr	20.5 Cr	13.3 Cr
Stores and Spare	0	0	239 Cr	196.8 Cr
Sundry Debtors	339 Cr	508.2 Cr	484.4 Cr	427.5 Cr
Debtors more than Six months	6.2 Cr	44.4 Cr	17.5 Cr	21.1 Cr
Debtors Others	339 Cr	473.8 Cr	475.2 Cr	416.6 Cr
Cash and Bank	638.2 Cr	515.1 Cr	509.3 Cr	528.2 Cr
Balances at Bank	638.2 Cr	515.1 Cr	509.3 Cr	528.2 Cr
Other Current Assets	173.9 Cr	157 Cr	140.1 Cr	111.3 Cr
Interest accrued and or due on loans	12.7 Cr	32.9 Cr	39.3 Cr	16.4 Cr
Prepaid Expenses	24.2 Cr	28.2 Cr	31.2 Cr	16.4 Cr
Short Term Loans and Advances	167 Cr	80.1 Cr	64.3 Cr	58.2 Cr
Advances recoverable in cash or in kind	141.1 Cr	32.4 Cr	29.2 Cr	38.7 Cr
Total Current Assets	1801 Cr	2203.6 Cr	2355.3 Cr	1851.8 Cr
Net Current Assets (Including Current Investments)	670.6 Cr	972.1 Cr	1198 Cr	753.2 Cr
Total Assets	4788.8 Cr	5495.7 Cr	5768.5 Cr	5784.1 Cr
Contingent Liabilities	429.9 Cr	547.8 Cr	1243.8 Cr	632.1 Cr
Total Debt	772.3 Cr	789.6 Cr	575.3 Cr	141.7 Cr
Book Value	68.54	0	88.59	103.83
Adjusted Book Value	68.54	79.97	88.59	103.83

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	10.12	9.88	11.57	12.69
CEPS(Rs)	16.99	17.6	20.7	23.28
DPS(Rs)	0	1	1.25	1.25
Book NAV/Share(Rs)	68.61	80.09	88.51	104.19
Tax Rate(%)	13.7	18.29	21.77	17.85
Margin Ratios
Core EBITDA Margin(%)	29.9	28.43	29.21	29.05
EBIT Margin(%)	22.75	19.53	20.01	19.13
Pre Tax Margin(%)	21.48	18.6	18.59	17.78
PAT Margin (%)	18.54	15.2	14.54	14.6
Cash Profit Margin (%)	31.1	27.09	26.02	26.8
Performance Ratios
ROA(%)	9.17	7.69	8.25	8.59
ROE(%)	16.59	13.29	13.73	13.18
ROCE(%)	15.4	13.24	15.43	15.55
Asset Turnover(x)	0.49	0.51	0.57	0.59
Sales/Fixed Asset(x)	0.69	0.71	0.76	0.74
Working Capital/Sales(x)	3.24	2.67	2.58	4.29
Efficiency Ratios
Fixed Capital/Sales(x)	1.46	1.4	1.31	1.35
Receivable days	61.61	68.92	59.27	50.73
Inventory Days	7.09	16.75	29.28	29.85
Payable days	50.33	115.59	-2132.64	1652.8
Valuation Parameters
PER(x)	53.68	60.44	51.39	55.31
PCE(x)	31.99	33.91	28.72	30.14
Price/Book(x)	7.92	7.45	6.72	6.73
Yield(%)	0	0.17	0.21	0.18
EV/Net Sales(x)	10.01	9.29	7.49	7.97
EV/Core EBITDA(x)	29.69	28.5	23.78	25.15
EV/EBIT(x)	44	47.58	37.43	41.6
EV/CE(x)	4.56	4.4	4.15	6.32
M Cap / Sales	9.95	9.19	7.47	8.09
Growth Ratio
Net Sales Growth(%)	8.57	19.22	22.61	9.26
Core EBITDA Growth(%)	5.28	15.28	18.42	9.92
EBIT Growth(%)	-9.9	2.33	25.62	4.57
PAT Growth(%)	-1.75	-2.25	17.33	9.82
EPS Growth(%)	-1.75	-2.44	17.16	9.66
Financial Stability Ratios
Total Debt/Equity(x)	0.28	0.25	0.16	0.03
Current Ratio(x)	1.59	1.8	2.04	1.71
Quick Ratio(x)	1.55	1.65	1.76	1.52
Interest Cover(x)	17.94	21.1	14.13	14.15
Total Debt/Mcap(x)	0.04	0.03	0.02	0.01

FINANCIAL RATIOS (STANDALONE) FOR SYNGENE INTERNATIONAL LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	10.09	9.83	11.78	11.6
CEPS(Rs)	16.96	17.55	20.73	20.78
DPS(Rs)	0	1	1.25	1.25
Book NAV/Share(Rs)	68.54	79.97	88.59	103.83
Tax Rate(%)	13.63	18.25	21.28	16.29
Margin Ratios
Core EBITDA Margin(%)	29.88	28.36	29.2	27.4
EBIT Margin(%)	22.72	19.44	20.23	18.3
Pre Tax Margin(%)	21.45	18.52	18.82	17.38
PAT Margin (%)	18.52	15.14	14.81	14.55
Cash Profit Margin (%)	31.12	27.04	26.06	26.05
Performance Ratios
ROA(%)	9.15	7.66	8.4	8.08
ROE(%)	16.56	13.25	13.99	12.07
ROCE(%)	15.35	13.19	15.61	13.76
Asset Turnover(x)	0.49	0.51	0.57	0.56
Sales/Fixed Asset(x)	0.68	0.71	0.81	0.77
Working Capital/Sales(x)	3.25	2.68	2.67	4.26
Efficiency Ratios
Fixed Capital/Sales(x)	1.46	1.4	1.23	1.29
Receivable days	61.73	68.93	56.72	51.89
Inventory Days	7.1	16.77	29.27	32.26
Payable days	50.72	115.59	-2153.93	1658.62
Valuation Parameters
PER(x)	53.84	60.75	50.45	60.47
PCE(x)	32.05	34.01	28.68	33.77
Price/Book(x)	7.93	7.46	6.71	6.76
Yield(%)	0	0.17	0.21	0.18
EV/Net Sales(x)	10.03	9.3	7.49	8.69
EV/Core EBITDA(x)	29.77	28.6	23.81	28.78
EV/EBIT(x)	44.17	47.84	37.04	47.41
EV/CE(x)	4.57	4.4	4.15	6.42
M Cap / Sales	9.97	9.2	7.47	8.81
Growth Ratio
Net Sales Growth(%)	8.33	19.36	22.76	0.3
Core EBITDA Growth(%)	5.2	15.19	18.79	-3.83
EBIT Growth(%)	-10.03	2.16	27.74	-9.18
PAT Growth(%)	-1.9	-2.45	20.11	-1.37
EPS Growth(%)	-1.9	-2.65	19.93	-1.52
Financial Stability Ratios
Total Debt/Equity(x)	0.28	0.25	0.16	0.03
Current Ratio(x)	1.59	1.79	2.04	1.69
Quick Ratio(x)	1.55	1.64	1.75	1.49
Interest Cover(x)	17.87	20.99	14.29	19.89
Total Debt/Mcap(x)	0.04	0.03	0.02	0.01

SHARE HOLDING PATTERN FOR SYNGENE INTERNATIONAL LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	70.29	64.86	64.86	54.88	54.80	54.79	54.79	54.79	54.72	54.72
FII %	14.12	16.77	16.85	23.29	23.19	23.55	21.20	20.92	20.64	20.72
DII %	1.20	1.79	1.70	1.80	1.77	1.76	1.55	1.49	1.17	1.00
Public %	11.39	11.59	11.25	11.10	10.82	9.95	9.38	8.49	7.86	7.07

PEER COMPARISON FOR SYNGENE INTERNATIONAL LIMITED

No.	Name
1	FGP LTD
2	JAYKAY ENTERPRISES LTD
3	MPIL CORPORATION LTD
4	Modi Rubber Limited
5	MODIPON LTD
6	RAJASTHAN PETRO SYNTHETICS LTD
7	Pressman Advertising Limited
8	PTL Enterprises Limited
9	HIMALAYA GRANITES LTD
10	Arrow Greentech Limited
11	Starlog Enterprises Ltd
12	Safari Industries (India) Limited
13	Vimta Labs Limited
14	Standard Industries Limited
15	Sanghvi Movers Limited
16	GSL Nova Petrochemicals Limited
17	Delta Corp Limited
18	Sun Pharma Advanced Research Company Limited
19	GKW Limited
20	Aarvi Encon Limited
21	Syngene International Limited
22	VA Tech Wabag Limited
23	Healthcare Global Enterprises Limited
24	Yaari Digital Integrated Services Limited
25	SIS LIMITED
26	Just Dial Limited
27	Future Enterprises Limited
28	Gujarat NRE Coke Ltd
29	Teamlease Services Limited
30	KESAR TERMINALS & INFRASTRUCTURE LTD
31	Future Market Networks Limited
32	Jain Irrigation Systems Limited
33	JAIN IRRIGATION SYSTEMS LTD
34	RattanIndia Enterprises Limited
35	Spacenet Enterprises India Limited
36	Quess Corp Limited
37	Universus Photo Imagings Limited
38	Antony Waste Handling Cell Limited
39	BLS International Services Limited
40	Vertoz Advertising Limited
41	Touchwood Entertainment Limited
42	Ajooni Biotech Limited
43	Kapston Services Limited
44	Indiabulls Enterprises Limited

CORPORATE ACTIONS FOR SYNGENE INTERNATIONAL

Exchange Date	Purpose	Book Closure Dates
BSE 04-Oct-2024	Board Meeting - Quarterly Results	23-Oct-2024
BSE 28-Jun-2024	Dividend - Rs.1.2500 per share(12.5%)Final Dividend
BSE 28-Jun-2024	Board Meeting - Quarterly Results	24-Jul-2024
BSE 01-Apr-2024	Board Meeting - Final Dividend & Audited Results	24-Apr-2024
BSE 26-Dec-2023	Board Meeting - Quarterly Results	25-Jan-2024
BSE 06-Oct-2023	Board Meeting - Quarterly Results	17-Oct-2023
BSE 13-Jul-2023	Board Meeting - Quarterly Results	26-Jul-2023
BSE 30-Jun-2023	Dividend - Rs.0.7500 per share(7.5%)Special Dividend
BSE 26-Apr-2023	AGM - Inter alia, approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/- (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders? approval at the ensuing Annual General Meeting of the Company. The record date i...	26-Jul-2023
BSE 10-Apr-2023	Board Meeting - Final Dividend & Audited Results	26-Apr-2023
BSE 06-Jan-2023	Board Meeting - Quarterly Results	23-Jan-2023
BSE 06-Oct-2022	Board Meeting - Quarterly Results	19-Oct-2022
BSE 29-Aug-2022	SAST - In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has entered into an agreement for the purpose of acquisition of renewable power by acquiring equity stake up to 26% in O2 Renewable Energy II Private Limited ('O2'), Special Purpose Vehicle formed by O2 Energy SG Pte Ltd, for generation and supply of renewab...
BSE 12-Jul-2022	SAST - In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has entered intoan agreement for the purpose of acquisition of renewable power by acquiring equity stake up to 26% in Ampyr Renewable Energy Resources Eleven Private Limited('AREREPL'), Special Purpose Vehicle formed by Ampyr India Asset Holdings Private Lim...
BSE 04-Jul-2022	Board Meeting - Quarterly Results	20-Jul-2022
BSE 30-Jun-2022	Dividend - 19/08/2022 Equity Rs.0.5000 per share(5%)Special Dividend
BSE 28-Apr-2022	AGM - Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered andapproved the following:1. Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 pershare and a special additional dividend of Re. 0.50 per share) for the Financial year ...	20-Jul-2022
BSE 27-Apr-2022	Dividend - Rs.0.5000 per share(5%)Final Dividend
BSE 05-Apr-2022	Board Meeting - Final Dividend & Audited Results	27-Apr-2022
BSE 04-Jan-2022	Board Meeting - Quarterly Results	19-Jan-2022
BSE 04-Oct-2021	Board Meeting - Quarterly Results	20-Oct-2021

CORPORATE ANNOUNCEMENTS FOR SYNGENE INTERNATIONAL

Exchange Date	Category File	Description
BSE 29-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the link for the transcript of the Q2 FY2025 Earnings Call conducted on October 24 2024 and uploaded on the Companys website.
BSE 24-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) please find the link for the audio recording of the Q2 FY25 Earnings Call conducted on October 24 2024 and uploaded on the website of the Company on October 24 2024.
BSE 24-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement - Financial Results
BSE 23-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation for the quarter and half year ended September 30 2024.
BSE 23-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release dated October 23 2024.
BSE 23-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Change in Management.
BSE 23-Oct-2024	General Announcements FILE	Change In Internal Auditors. Change in Internal Auditors.
BSE 23-Oct-2024	Outcome FILE	Unaudited Financial Results For The Quarter And Half Year Ended September 30 2024 Unaudited Financial Results for the quarter and half year ended September 30 2024.
BSE 23-Oct-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting - October 23 2024. Outcome of the Board Meeting - October 23 2024.
BSE 18-Oct-2024	General Announcements FILE	Intimation Of Receipt Of Refund Order From The Income Tax Department. Intimation of receipt of refund order from the Income Tax Department.
BSE 16-Oct-2024	General Announcements FILE	Intimation Of Submission Of A Writ Petition Against Income Tax Orders. Intimation of submission of a writ petition against Income Tax Orders.
BSE 14-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the intimation for the conference call for Analysts and Investors to be held on Thursday October 24 2024.
BSE 07-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018.
BSE 04-Oct-2024	Intimation FILE	Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ending September 30 2024 Amongst Other Routine Matters. Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30 2024 amongst other routine matters.
BSE 01-Oct-2024	General Announcements FILE	Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 ('Plan'). Grant of Performance Share Units under Syngene Long-Term Incentive Performance Share Plan 2023 ("Plan").
BSE 01-Oct-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
BSE 27-Sep-2024	Intimation FILE	Closure of Trading Window Intimation of closure of trading window.
BSE 24-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 20-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 19-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 18-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 18-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 14-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 12-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 09-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the details of the meeting to be held with the Analyst/ Institutional Investor.
BSE 03-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 03-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 02-Sep-2024	General Announcements FILE	Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 ('Plan'). Grant of Performance Share Units under Syngene Long-Term Incentive Performance Share Plan 2023 ("Plan").
BSE 30-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the details of the meeting to be held with the Analyst/Institutional Investor.
BSE 21-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the details of the meeting to be held with the Analyst/ Institutional Investor.

INSIDER TRADING FOR SYNGENE INTERNATIONAL

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 04-Sep-2024 04-Sep-2024	Sell Market	2,394 @ 0.00 (0.00 %)	CHETAN PRAKASH TAMHANKAR
BSE 04-Sep-2024 04-Sep-2024	Sell Market	2,587 @ 0.00 (0.00 %)	AJIT MANOCHA
BSE 03-Sep-2024 03-Sep-2024	Sell Market	2,500 @ 0.00 (0.00 %)	AJIT MANOCHA
BSE 28-Aug-2024 28-Aug-2024	Sell Market	5,000 @ 0.00 (0.00 %)	AJIT MANOCHA
BSE 26-Aug-2024 26-Aug-2024	Sell Market	1,000 @ 0.00 (0.00 %)	ALOK MEHROTRA
BSE 27-Aug-2024 27-Aug-2024	Sell Market	500 @ 0.00 (0.00 %)	ALOK MEHROTRA
BSE 26-Aug-2024 26-Aug-2024	Sell Market	5,000 @ 0.00 (0.00 %)	G KRISHNAN
BSE 26-Aug-2024 26-Aug-2024	Sell Market	6,400 @ 0.00 (0.00 %)	MANOJ GUPTA
BSE 16-Aug-2024 16-Aug-2024	Sell Market	5,000 @ 0.00 (0.00 %)	MOHAN K
BSE 13-Aug-2024 13-Aug-2024	Buy ESOP	17,287 @ 0.00 (0.01 %)	PURUSHOTTAM SHASHIKANT SINGNURKAR
BSE 13-Aug-2024 13-Aug-2024	Sell Market	7,100 @ 0.00 (0.01 %)	PURUSHOTTAM SHASHIKANT SINGNURKAR
BSE 13-Aug-2024 13-Aug-2024	Buy ESOP	6,400 @ 0.00 (0.00 %)	SRIDEVI KHAMBHAMPATY
BSE 13-Aug-2024 13-Aug-2024	Sell Market	2,400 @ 0.00 (0.00 %)	SRIDEVI KHAMBHAMPATY
BSE 13-Aug-2024 13-Aug-2024	Buy ESOP	20,743 @ 0.00 (0.00 %)	RAJENDRA D PATIL
BSE 13-Aug-2024 13-Aug-2024	Sell Market	8,500 @ 0.00 (0.00 %)	RAJENDRA D PATIL
BSE 13-Aug-2024 13-Aug-2024	Buy ESOP	10,373 @ 0.00 (0.00 %)	G KRISHNAN
BSE 13-Aug-2024 13-Aug-2024	Sell Market	4,300 @ 0.00 (0.00 %)	G KRISHNAN
BSE 12-Aug-2024 12-Aug-2024	Sell Market	128,291 @ 0.00 (0.03 %)	JONATHAN HUNT
BSE 12-Aug-2024 12-Aug-2024	Buy ESOP	138,291 @ 0.00 (0.03 %)	JONATHAN HUNT
BSE 12-Aug-2024 12-Aug-2024	Sell Market	10,000 @ 0.00 (0.00 %)	JONATHAN HUNT
BSE 09-Aug-2024 09-Aug-2024	Buy ESOP	17,287 @ 0.00 (0.00 %)	AJIT MANOCHA
BSE 09-Aug-2024 09-Aug-2024	Sell Market	7,200 @ 0.00 (0.00 %)	AJIT MANOCHA
BSE 09-Aug-2024 09-Aug-2024	Sell Market	4,000 @ 0.00 (0.00 %)	ANANDA POOJARY
BSE 09-Aug-2024 09-Aug-2024	Sell Market	6,800 @ 0.00 (0.00 %)	KENNETH JAY BARR
BSE 09-Aug-2024 09-Aug-2024	Buy ESOP	10,373 @ 0.00 (0.00 %)	ANANDA POOJARY
BSE 09-Aug-2024 09-Aug-2024	Buy ESOP	16,594 @ 0.00 (0.00 %)	KENNETH JAY BARR
BSE 09-Aug-2024 09-Aug-2024	Buy ESOP	10,373 @ 0.00 (0.00 %)	MANOJ GUPTA
BSE 09-Aug-2024 09-Aug-2024	Sell Market	3,900 @ 0.00 (0.00 %)	PRIYADARSHINI MAHAPATRA
BSE 09-Aug-2024 09-Aug-2024	Buy ESOP	10,000 @ 0.00 (0.00 %)	PRIYADARSHINI MAHAPATRA
BSE 09-Aug-2024 09-Aug-2024	Sell Market	3,973 @ 0.00 (0.00 %)	MANOJ GUPTA

BULK BLOCK DEALS FOR SYNGENE INTERNATIONAL LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 01-Feb-2023	Sell BULK	40,000,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Buy BULK	15,799,200 @ 560.00	GOVERNMENT OF SINGAPORE
BSE 01-Feb-2023	Buy BLOCK	55,500 @ 560.00	ABS DIRECT EQUITY FUND LLC - INDIA SERIES 1
BSE 01-Feb-2023	Buy BLOCK	214,285 @ 560.00	ABSL UMBRELLA UCITS FUND PLC - INDIA FRONTLINE EQUITY FUND
BSE 01-Feb-2023	Buy BLOCK	625,000 @ 560.00	ABU DHABI INVESTMENT AUTHORITY
BSE 01-Feb-2023	Buy BLOCK	71,120 @ 560.00	ADITYA BIRLA SUN LIFE MUTUAL FUND
BSE 01-Feb-2023	Buy BLOCK	570,560 @ 560.00	ADITYA BIRLA SUN LIFE MUTUAL FUND
BSE 01-Feb-2023	Buy BLOCK	238,000 @ 560.00	AL MEHWAR COMMERCIAL INVESTMENTS LLC
BSE 01-Feb-2023	Buy BLOCK	135,000 @ 560.00	ASHOKA INDIA EQUITY INVESTMENT TRUST PLC
BSE 01-Feb-2023	Buy BLOCK	180,000 @ 560.00	AURIGIN MASTER FUND LIMITED
BSE 01-Feb-2023	Buy BLOCK	180,000 @ 560.00	AVENDUS ABSOLUTE RETURN FUND
BSE 01-Feb-2023	Buy BLOCK	550,000 @ 560.00	BAJAJ ALLIANZ LIFE INSURANCE COMPANY LIMITED
BSE 01-Feb-2023	Sell BLOCK	180,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	193,799 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	195,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	239,100 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	250,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	275,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	285,434 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	300,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	304,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	320,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	342,355 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	357,142 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	400,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	401,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	550,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	600,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	900,000 @ 560.00	BIOCON LIMITED
BSE 01-Feb-2023	Sell BLOCK	1,035,670 @ 560.00	BIOCON LIMITED

DIVIDEND BY SYNGENE INTERNATIONAL LIMITED

Ex Dividend Date	Dividend Type	Dividend
28-Jun-2024	DIVIDEND	1.25
30-Jun-2023	DIVIDEND	0.5
30-Jun-2023	SPECIAL DIVIDEND	0.75
30-Jun-2022	DIVIDEND	0.5
30-Jun-2022	SPECIAL DIVIDEND	0.5

SPLIT / BONUS BY SYNGENE INTERNATIONAL LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Syngene International Limited

Syngene International share price

CONSOLIDATED QUARTERLY RESULT FOR SYNGENE INTERNATIONAL LIMITED

STANDALONE QUARTERLY RESULT FOR SYNGENE INTERNATIONAL LIMITED

CONSOLIDATED ANNUAL RESULT FOR SYNGENE INTERNATIONAL LIMITED

STANDALONE ANNUAL RESULT FOR SYNGENE INTERNATIONAL LIMITED

CONSOLIDATED PROFIT / LOSS FOR SYNGENE INTERNATIONAL LIMITED

STANDALONE PROFIT / LOSS FOR SYNGENE INTERNATIONAL LIMITED

CONSOLIDATED CASH FLOW FOR SYNGENE INTERNATIONAL LIMITED

STANDALONE CASH FLOW FOR SYNGENE INTERNATIONAL LIMITED

CONSOLIDATED BALANCE SHEET FOR SYNGENE INTERNATIONAL LIMITED

STANDALONE BALANCE SHEET FOR SYNGENE INTERNATIONAL LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR SYNGENE INTERNATIONAL LIMITED

FINANCIAL RATIOS (STANDALONE) FOR SYNGENE INTERNATIONAL LIMITED

SHARE HOLDING PATTERN FOR SYNGENE INTERNATIONAL LIMITED

PEER COMPARISON FOR SYNGENE INTERNATIONAL LIMITED

CORPORATE ACTIONS FOR SYNGENE INTERNATIONAL

CORPORATE ANNOUNCEMENTS FOR SYNGENE INTERNATIONAL

INSIDER TRADING FOR SYNGENE INTERNATIONAL

BULK BLOCK DEALS FOR SYNGENE INTERNATIONAL LIMITED

DIVIDEND BY SYNGENE INTERNATIONAL LIMITED

SPLIT / BONUS BY SYNGENE INTERNATIONAL LIMITED